Could a diabetes drug curb cocaine cravings? new trial aims to find out
NCT ID NCT07227948
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether semaglutide, a drug used for diabetes and weight loss, can help people with cocaine use disorder reduce their cocaine use. About 75 adults will receive semaglutide along with counseling. Researchers will measure changes in brain responses, cravings, and drug use over the treatment period.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCAINE USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas Health Science Center at Houston
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Weight-Loss drug may curb stimulant cravings, brain scans suggest
- Brain scans reveal how stress fuels cocaine relapse
- Scientists scan brains of cocaine users to uncover dopamine secrets
- Sound waves against addiction: ultrasound zaps cocaine cravings
- Magic mushroom compound tested to help people quit cocaine
- New drug tested against cocaine: no cure, just safety check